PRA-216
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRA-216, covering 2026-03-20 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma [Phase 1, Phase 2]